Kinematics-Based Prediction of Chronic Pain After Combat-Related Extremity Trauma (NCT07432685) | Clinical Trial Compass
By InvitationNot Applicable
Kinematics-Based Prediction of Chronic Pain After Combat-Related Extremity Trauma
Ukraine100 participantsStarted 2026-03-12
Plain-language summary
Combat-related extremity trauma frequently results in persistent pain, including neuropathic, residual limb, and phantom limb pain. The kinematics of injury-including energy level, direction of force, and dominant force components-may independently predict tissue deformation, nerve stress, and the transition from acute to chronic- pain. This prospective observational cohort study will assess whether kinematics-only variables predict chronic pain outcomes after combat-related upper and lower limb injuries. Pain outcomes will include pain intensity, pain extent (surface/area), neuropathic pain features, and mechanical pain sensitivity measured using von Frey filaments.
Who can participate
Age range
18 Years – 50 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Age ≥18 years
* Combat-related extremity trauma involving upper and/or lower limbs
* Blunt limb trauma
* Penetrating limb injury (ballistic or shrapnel)
* Blast-related limb injury
* Hybrid injury (blast plus fragment)
* тTraumatic amputation (partial or complete)
* Baseline assessment performed within 72 hours of injury
* Acute limb pain with Numeric Rating Scale (NRS) score ≥3 at baseline
* Ability to provide informed consent
* Ability to participate in follow-up assessments
Exclusion Criteria:
* Inability to complete follow-up assessments
* Severe cognitive impairment preventing informed consent
* Declines participation
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
What they're measuring
1
Chronic limb pain at 3 months
Timeframe: Assessed at 3 months (90 days ± 14 days) after injury Pain assessment will be conducted during the scheduled 3-month follow-up visit (between Day 76 and Day 104 post-injury).
Trial details
NCT IDNCT07432685
SponsorCharitable Organisation Charitable Fund Superhumans (Co Cf Superhumans)